Sonnest, Inc.

medical devices

About

Sonnest, Inc. is pre-clinical healthcare company developing Electrast™, an ultrasound imaging drug that circulates through the body in the inactive state (dark on ultrasound) and is selectively activated (turned on) in the myocardium. With Electrast™ doctors will be able to evaluate perfusion of the heart quickly and cost-effectively at the point of care without exposure to ionizing radiation or toxic dies. The technology was developed by a talented team of cardiologists and chemical engineers at Drexel University with grant funding from the Coulter-Drexel Program and the inventors partnered with a team of successful serial healthcare entrepreneurs who have worked together for over 15 years across multiple companies to form Sonnest.

Technologies

Flywheel Node.js IoT Android Python Remote AI

Keywords

medical equipment manufacturing ultrasound technology biotechnology myocardial perfusion medical imaging innovation biotech startup diagnostic imaging cardiology research healthcare technology ultrasound imaging cost-effective diagnosis cardiac assessment risk assessment clinical trials electrical field imaging non-radiative imaging imaging agent activation voltage-activated imaging heart structure and function medical device innovation ultrasound contrast agent medical technology point of care imaging perfusion imaging cardiac viability assessment patient care voltage-sensitive contrast agent cardiac imaging cardiology diagnostics medical imaging research

Location

323 W Camden St, Baltimore, Maryland, United States, 21201

Related Companies

Companies in the same industry